Severe Cytokine Release Syndrome After Basiliximab Induction Therapy

被引:0
|
作者
Singhal, A. L. [1 ]
Ahmad, K. [1 ]
Brown, A. W. [1 ]
King, C. [1 ]
Khangoora, V. [1 ]
Aryal, S. [1 ]
Marinak, L. M. [1 ]
Tang, D. [2 ]
Nathan, S. D. [1 ]
Shlobin, O. A. [1 ]
机构
[1] INOVA Fairfax Hosp, Adv Lung Dis & Lung Transplant, Falls Church, VA USA
[2] INOVA Fairfax Hosp, Cardiothorac Surg, Falls Church, VA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2347
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Are There Real Advantages of Induction Therapy With Basiliximab in Renal Transplantation?
    Teixeira, C.
    Bouazzaoui, Z.
    Guerra, J.
    Raimundo, M.
    Santana, A.
    Mil-Homens, M. C.
    Gomes da Costa, A.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (03) : 1073 - 1075
  • [42] Induction of cytokine release after mechanical stress in trabecular meshwork cells
    Liton, PB
    Caballero, M
    Gonzalez, P
    Epstein, DL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U308 - U308
  • [43] Pulmonary fibrosis and cytokine release syndrome after hyperactivation with sintilimab
    Hu, Jing
    Li, Yanxiu
    Chen, Xuesong
    Luo, Can
    Zuo, Xiangrong
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (06) : 1474 - 1477
  • [44] Cytokine Release Syndrome after Haploidentical Stem Cell Transplantation
    Teachey, David T.
    Grupp, Stephan A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1736 - 1737
  • [45] Cytokine release syndrome after CAR T-cell therapy: a review of the literature and our experience
    Cemusova, B.
    ANESTEZIOLOGIE A INTENZIVNI MEDICINA, 2022, 33 (02): : 90 - 96
  • [46] Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
    Fitzgerald, Julie C.
    Weiss, Scott L.
    Maude, Shannon L.
    Barrett, David M.
    Lacey, Simon F.
    Melenhorst, J. Joseph
    Shaw, Pamela
    Berg, Robert A.
    June, Carl H.
    Porter, David L.
    Frey, Noelle V.
    Grupp, Stephan A.
    Teachey, David T.
    CRITICAL CARE MEDICINE, 2017, 45 (02) : E124 - E131
  • [47] Successful desensitization to nivolumab after a refractory severe cytokine release reaction
    De las Vecillas, L.
    Gutierrez, A.
    Montenegro, E.
    Lopez, J.
    Morchon, E.
    Rodriguez, F.
    King, K.
    Sanchez, L.
    Duran, I
    Pena, C.
    Caso, V
    Castanedo, P.
    ALLERGY, 2021, 76 : 262 - 262
  • [48] A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19
    Reis, Ruy Freitas
    Pigozzo, Alexandre Bittencourt
    Barbosa Bonin, Carla Rezende
    Quintela, Barbara de Melo
    Pompei, Lara Turetta
    Vieira, Ana Carolina
    e Silva, Larissa de Lima
    Xavier, Maicom Peters
    dos Santos, Rodrigo Weber
    Lobosco, Marcelo
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [49] Immunosafety of AAV Gene Therapy Vectors: Induction of Cytokine Release and Complement Activation
    Xicluna, Rebecca
    Seeger, Emily
    Heeren, Julian Freen-van
    Turksma, Annelies
    Opstelten, Rianne
    Schwandt, Timo
    Schwalie, Petra
    Von Tell, Desiree
    Bell, Emma
    Haegel, Helene
    MOLECULAR THERAPY, 2023, 31 (04) : 773 - 774
  • [50] Immunosafety of AAV Gene Therapy Vectors: Induction of Cytokine Release and Complement Activation
    Xicluna, Rebecca
    Farny, Monique
    Ashoff, Mailin
    Fankhauser, Aline
    Heeren, Julian Freen-Van
    Turksma, Annelies
    Opstelten, Rianne
    Schwandt, Timo
    Haegel, Helene
    MOLECULAR THERAPY, 2022, 30 (04) : 334 - 334